Mechanism of protection against vascular smoking-induced changes by hormone replacement therapy.
Hellstrom
H R
HR
D001158:Arteries / Q000473:pathology* / Q000503:physiopathology; D001241:Aspirin / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D017202:Myocardial Ischemia / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017698:Postmenopause / Q000502:physiology; D012907:Smoking / Q000009:adverse effects*; D014652:Vascular Diseases / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D014655:Vascular Resistance; D014810:Vitamin E / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D014810:Vitamin E; D001241:Aspirin